Reading Hospital McGlinn Cancer Institute at Phoenixville is a clinical research site located in Phoenixville, Pennsylvania, United States 19460.
Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Reading Hospital McGlinn Cancer Institute at Phoenixville has participated in 22 clinical trials with 20 currently active.
Therapeutic areas: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8.
Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), NRG Oncology.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Phoenixville
Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Reading Hospital McGlinn Cancer Institute at Phoenixville has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Reading Hospital McGlinn Cancer Institute at Phoenixville has 22 clinical trials on record, with 20 currently active. Their work covers Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8.
Reading Hospital McGlinn Cancer Institute at Phoenixville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.